Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Pathways
Pathways Reduce Care Variation and Cost of Care, Improve Overall Outcomes
By
Wayne Kuznar
Pathways
June 2015, Vol 6, No 5
Washington, DC—The establishment of pathways in oncology can reduce care variation and enhance value in patient care, said Michael Kolodziej, MD, National Medical Director, Oncology Solutions, Aetna, at the Fifth Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Pathways Have the Potential to Deliver Personalized Medicine
By
Wayne Kuznar
Pathways
May 2015, Vol 6, No 4
Washington, DC—The institution of cancer treatment pathways is not incompatible with personalized medicine, but rather it has the potential to offer access to a rapid learning system that can promote personalized therapy, said Michael Kolodziej, MD, National Medical Director, Oncology Solutions, Aetna, at the Fifth Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Secondary Oncology Pathways Can Have Big Cost Impact
By
Kate O'Rourke
Economics & Value
,
Economics of Cancer Care
,
Pathways
August 2014, Vol 5, No 6
Chicago, IL—The implementation of collaborative, secondary clinical pathway programs can improve outcomes and can lower costs when providers are already participating in another payer-sponsored pathway program. This conclusion comes from a study published online in conjunction with the 2014 American Society of Clinical Oncology meeting.
Read Article
Cancer Care Pathways
By
Mark J. Krasna, MD
Pathways
Videos
Listen as Dr. Mark Kransa explain why the use of cancer care pathways is a method of dimishing the variance in cancer care in chemotherapy infusion and radiation therapy.
Read Article
New Pathways, Targeted Therapies Being Explored in Hepatocellular Carcinoma
By
Wayne Kuznar
Pathways
,
Policies & Guidelines
March 2014, Vol 5, No 2
San Francisco, CA—Many molecularly targeted agents that inhibit different pathways of hepatocarcinogenesis are under development, and novel targets are being assessed in hepatocellular carcinoma (HCC), said Andrew X. Zhu, MD, PhD, Director, Liver Cancer Research, Massachusetts General Hospital, Boston, at the 2014 Gastrointestinal Cancers Symposium.
Read Article
Virtual Patients Help Identify Opportunities for Cost-Savings
By
Charles Bankhead
Pathways
,
Policies & Guidelines
March 2014, Vol 5, No 2
San Diego, CA—The use of virtual patient vignettes to improve adherence to a breast cancer clinical pathway identified correctable variances from a breast cancer clinical pathway with the potential to reduce the cost of care by several million dollars, according to the results of a pilot study reported at the 2013 American Society of Clinical Oncology Quality Care Symposium.
Read Article
Pathways Creating More and More Value
Pathways
June 2013, Vol 4, No 5
Pathways continue to be refined toward value-based care, adapting to the challenges of a rapidly shifting oncology landscape, as 2 speakers at the Third Annual Conference of the Association for Value-Based Cancer Care described.
Read Article
Pathway Compliance Reduces Drug, Nondrug Expenses
Pathways
,
Policies & Guidelines
July/August 2010, Vol 1, No 3
Evaluation of a regional payer-based pay-for-quality (P4Q)oncology program showed thatPathways programs can greatly reduce the cost of cancer care by slowingthe growth rate of both drug andnondrug expenses.
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Perioperative Nivolumab Extends Event-Free Survival in Resectable NSCLC
William King
2.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
3.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma